Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-11-24
pubmed:abstractText
To investigate long-term swallowing function in oropharyngeal cancer patients treated with intensity-modulated radiotherapy (IMRT), and to identify novel dose-limiting criteria predictive for dysphagia.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1879-355X
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1356-65
pubmed:meshHeading
pubmed-meshheading:20646872-Adult, pubmed-meshheading:20646872-Aged, pubmed-meshheading:20646872-Analysis of Variance, pubmed-meshheading:20646872-Carcinoma, Squamous Cell, pubmed-meshheading:20646872-Combined Modality Therapy, pubmed-meshheading:20646872-Deglutition, pubmed-meshheading:20646872-Deglutition Disorders, pubmed-meshheading:20646872-Female, pubmed-meshheading:20646872-Humans, pubmed-meshheading:20646872-Laryngeal Muscles, pubmed-meshheading:20646872-Male, pubmed-meshheading:20646872-Middle Aged, pubmed-meshheading:20646872-Neoplasm Staging, pubmed-meshheading:20646872-Organs at Risk, pubmed-meshheading:20646872-Oropharyngeal Neoplasms, pubmed-meshheading:20646872-Oropharynx, pubmed-meshheading:20646872-Prospective Studies, pubmed-meshheading:20646872-Radiation Injuries, pubmed-meshheading:20646872-Radiation Protection, pubmed-meshheading:20646872-Radiotherapy, Intensity-Modulated, pubmed-meshheading:20646872-Radiotherapy Dosage, pubmed-meshheading:20646872-Tongue Neoplasms, pubmed-meshheading:20646872-Tonsillar Neoplasms, pubmed-meshheading:20646872-Tumor Burden
pubmed:year
2010
pubmed:articleTitle
Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
pubmed:affiliation
Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. docdls@mdanderson.org
pubmed:publicationType
Journal Article, Clinical Trial, Phase II, Research Support, N.I.H., Extramural